Q1 Results: Merck Benefits from Global Diversification in a Challenging Environment

Medium-term structural growth drivers intact

12-May-2023 - Merck generated net sales of €5.3billion in the first quarter of 2023. This corresponds to an increase of 1.8% over the year-earlier quarter (organically 0.8%). Sales growth was in particular attributable to Healthcare, which delivered significant increases in its business with new medicines, ...

Bayer: Slow start to the year as expected

Bayer Group business performance in the first quarter of 2023

11-May-2023 - The Bayer Group experienced a slow start to 2023 as expected. “Sales were on a par with the exceptionally strong prior-year quarter,” CEO Werner Baumann said on Thursday when presenting the Quarterly Statement for the first quarter. The normalization in the glyphosate business has accelerated, ...

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

The Company was previously affiliated with PerkinElmer, Inc.

11-May-2023 - Revvity, Inc. officiallylaunched as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. Born from two words, “revolutionize” (rev) and “vita” (vit) meaning “life” in Latin, Revvity delivers end-to-end expertise and ...

Bayer opens first Co.Lab Life science incubator in Cambridge

Supporting cutting-edge cell and gene therapy entrepreneurs

10-May-2023 - Bayer AG announced the inauguration of its new life science incubator dubbed “Co.Lab Cambridge” located in Kendall Square in Cambridge, U.S.. Bayer’s Co.Lab Cambridge is specifically designed to support cutting-edge cell and gene therapies (CGT) entrepreneurs with access to Bayer’s enterprise ...

Merck chief financial officer steps down

Helene von Roeder appointed Chief Financial Officer and Executive Board Member, effective July 1, 2023

09-May-2023 - Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board of Merck as of June30,2023. He will continue to serve as a Member of the Executive Board of E.MerckKG until July 31, 2024. The Board of Partners of E. Merck KG has appointed Helene von Roeder ...

LenioBio announces new CEO

Founder will be stepping down as CEO

09-May-2023 - LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, starting June 1st, 2023 André has previously held senior positions in ...

Pall and Cytiva join forces

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

02-May-2023 - Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. With nearly 16 000 associates in 40 countries, and more than 300 years' heritage of trusted expertise, the new Cytiva supports customers in solving ...

Sanofi completes acquisition of Provention Bio

02-May-2023 - Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per ...

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

Investment of 350 million euros is Boehringer Ingelheim's largest single investment in Germany to date

26-Apr-2023 - Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center (BDC) in Biberach an der Riß, Germany. The new high-tech facility underlines the company’s strong commitment to Germany and Europe as location for research and development (R&D) for the care of patients around ...

Newfound link between Alzheimer’s and iron could lead to new medical interventions

What if amyloid beta plaques aren’t the main cause of Alzheimer’s disease?

24-Apr-2023 - There is a growing body of evidence that iron in the brain may play a role in Alzheimer’s disease. Lending weight to that idea, a new imaging probe has for the first time shown that in the same regions of the brain where the amyloid beta plaques associated with Alzheimer’s occur, there is also an ...